Last price paid | 0.29 | |
Change | +3.57% [ +0.01 ] | |
Last traded volume | n.a. Unit | |
Cumulative volume | n.a. Unit | |
Date/time | 17.06.2024 17:20 |
Fixing | n.a. |
Settlement date | 12.03.2024 |
Last trading | n.a. |
Final fixing | n.a. |
Currency redemption | CHF |
Perf. since issue | -36.46% |
Year to date (YTD) | n.a. |
1 month | -44.23% |
3 months | -44.23% |
1 year | n.a. |
3 years | n.a. |
Issue price | 0.48 |
Underlying price on issue | 915.80 |
Premium | 0.01% |
Premium p.a. | n.a. |
Leverage | n.a. |
Implied volatility | n.a. |
ISIN | CH1305144078 |
Symbol | INOQ7Z |
Security | 130514407 |
Exchange | SIX Structured Products |
Currency | CHF |
Expiry | n.a. |
Underlying | Novo Nordisk -B-, DK0062498333 |
Underlying ISIN | DK0062498333 |
Funding level | 1091.325500 |
Stop-loss level | 1047.903600 |
Distance to stop-loss level | 6.91% |
Long/Short type | Short |
Subscription ratio | 50.00 |
Issuer | Zürcher Kantonalbank |
Exercise type | n.a. |
Minimum execution | n.a. |
Value day | 08.03.2024 |
Premium | 0.86% |
Premium p.a. | n.a. |
Leverage | 8.20 |
Moneyness | in-the-money |
Leverage | n.a. |
Delta | n.a. |
Intrinsic value | 111.125500 |
Break-even | n.a. |
SSPA value at risk | n.a. |
SSPA risk rating | n.a. |
SSPA derivative category | Leverage |
SSPA code | Mini future (2210) |
Name | Price |
---|---|
Lonza Group | 479.40 |
Swiss Life Hldg | 646.40 |
ABB Ltd | 50.86 |
Givaudan | 4'347.00 |
Holcim | 81.06 |
Name | Price |
---|---|
Compagnie Financi... | 141.00 |
Nestlé SA | 94.58 |
NOVARTIS N | 93.11 |
Alcon AG | 78.52 |
SONOVA HLDG N | 271.60 |